Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - DERMA SCIENCES, INC. | v432348_ex31-1.htm |
| 10-K - FORM 10-K - DERMA SCIENCES, INC. | v432348_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - DERMA SCIENCES, INC. | v432348_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - DERMA SCIENCES, INC. | v432348_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - DERMA SCIENCES, INC. | v432348_ex32-2.htm |
| EX-21.1 - EXHIBIT 21.1 - DERMA SCIENCES, INC. | v432348_ex21-1.htm |
| EX-10.41 - EXHIBIT 10.41 - DERMA SCIENCES, INC. | v432348_ex10-41.htm |
| EX-10.42 - EXHIBIT 10.42 - DERMA SCIENCES, INC. | v432348_ex10-42.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Derma Sciences, Inc.:
We consent to the incorporation by reference in the Registration Statements (No. 333-127527, 333-192848, and 333-197497) on Form S-8, in the Registration Statements (No. 333-163127 and No. 333-164942) on Form S-1 and Form S-1/MEF, respectively, and in the Registration Statements (Nos. 333-135038, 333-138303, 333-148332, 333-151028, 333-175421, 333-192945, and 333-193530) on Form S-3 or Form S-3/MEF, as applicable, of Derma Sciences, Inc. and subsidiaries of our reports dated March 15, 2016, with respect to the consolidated balance sheets of Derma Sciences, Inc. and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2015, and the effectiveness of internal control over financial reporting as of December 31, 2015, which reports appear in the December 31, 2015 Annual Report on Form 10-K of Derma Sciences, Inc.
/s/ KPMG LLP
Philadelphia, Pennsylvania
March 15, 2016